Becton, Dickinson and Company (BVMF:B1DX34)

Market Cap	310.69B
Revenue (ttm)	116.39B
Net Income (ttm)	8.94B
Shares Out	n/a
EPS (ttm)	31.02
PE Ratio	34.74
Forward PE	13.72
Dividend	3.08 (1.46%)
Ex-Dividend Date	Dec 5, 2025

Volume	15
Average Volume	41
Open	211.27
Previous Close	218.46
Day's Range	211.27 - 211.27
52-Week Range	183.35 - 286.00
Beta	0.45
RSI	53.00
Earnings Date	Feb 5, 2026

About BVMF:B1DX34

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: B1DX34

Financial Performance

In 2025, BVMF:B1DX34's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD